Celgene | search
Click here to view Celgene news from 60+ newspapers.
Bookmark or Share- REMS PATIENT SAFETYTo avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the REMS products THALOMID ® (thalidomide), POMALYST ® (pomalidomide), REVLIMID ® (lenalidomide) and generic lenalidomide. The THALOMID REMS ® program, Lenalidomide REMS program and POMALYST REMS ® program require prescribers and pharmacists to be certified and patients to enroll and ...
- REMS Prescriber Portal - bmsremspatientsafety.com©2024 Bristol-Myers Squibb Company Prescriber Login
- REMS Prescriber Portal - bmsremspatientsafety.comLos Fabricantes de Lenalidomida tienen un acuerdo contractual bajo el cual Celgene Corporation administra el programa REMS en nombre de los Fabricantes de Lenalidomida. Todos los fabricantes conservan la responsabilidad de las acciones descritas en el programa REMS.
- REMS Prescriber PortalThe Lenalidomide Manufacturers have a contractual agreement under which Celgene Corporation administers the REMS on behalf of the Lenalidomide Manufacturers. All manufacturers retain the responsibility for the actions described in the REMS.
- REMS Prescriber PortalTo login to your account: ...
More
